TIDES USA is the flagship must-attend event in the TIDES: Oligonucleotide & Peptide Therapeutics portfolio. It is the world’s largest gathering for those interested in accelerating oligonucleotide, peptide, mRNA and genome editing products from early discovery to late-stage development and commercialization. The program features 5 concurrent tracks covering the following 6 scientific themes including in-depth discovery, development and CMC strategies, trends, and technologies across the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing, with a strong focus on drug delivery strategies for these modalities.
Fill out the Form Below
TIDES USA 2026 TRACKS
Oligonucleotide Chemistry, Manufacturing & Controls
Oligonucleotide Discovery, Preclinical and Clinical
Peptide Chemistry, Manufacturing & Controls
Peptide Discovery, Preclinical and Clinical
mRNA Therapeutics/Vaccines & Genome Editing
Drug Delivery Innovations and Delivery of Macromolecules
Download the
TIDES USA 2026
Preliminary Agenda
"TIDES is a ‘must-go’ conference for scientists working in the peptide/oligonucleotide area."
George Wang, Analytical Chemist, Bristol-Myers Squibb
"A big thank you to entire TIDES staff and participants on your fantastic work. You have a top-notch operation. I always prefer to meet people face to face rather behind the machine but after my participation at TIDES virtual, it changed my perception inside out. It was very much like meeting people in real time.
- TIDES USA Virtual Attendee
"This was the BEST TIDES meeting that I have ever attended. In terms of both caliber of science, and interactions in the sessions and on the exhibit floor."
-Steven F. Dowdy, Ph.D., Professor Dept. of Cellular & Molecular Medicine